Mechanism-Based Screening Strategies for Anthelmintic Discovery

Parasitic Helminths: Targets, Screens, Drugs and Vaccines

Volumn , Issue , 2012, Pages 121-134

  Geary, Timothy G ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Anthelmintic drug; Enzyme inhibitor; High throughput screening; Mechanism based screening; Neuromuscular target

Indexed keywords

EID: 84886142543     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527652969.ch8     Document Type: Chapter

References (48)

1. Santiago-Stevenson, D., Oliver-Gonzalez, J., and Hewitt, R.I. (1947) Treatment of filariasis bancrofti with 1-diethylcarbamyl-4-methylpiperazine hydrochloride (.Hetrazan.). J. Am. Med. Assoc., 135, 708-712.
2. Geary, T.G., Woo, K., McCarthy, J.S., Mackenzie, C.D., Horton, J., Prichard, R.K., de Silva, N.R. et al. (2010) Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int. J. Parasitol., 40, 1-13.
3. Woods, D.J., Lauret, C., and Geary, T.G. (2007) Anthelmintic discovery and development in the animal health industry. Expert Opin. Drug Discov., 2 (Suppl. 1), S25-S33.
4. Geary, T.G. and Thompson, D.P. (2001) Caenorhabditis elegans: how good a model for veterinary parasites? Vet. Parasitol., 101, 371-386.
5. Ruiz-Lancheros, E., Viau, C.,Walter, T.N., Francis, A., and Geary, T.G. (2011) Activity of novel nicotinic anthelmintics in cut preparations of C. elegans. Int. J. Parasitol., 41, 455-461.
6. Thompson, D.P., Klein, R.D., and Geary, T.G. (1996) Prospects for rational approaches to anthelmintic discovery. Parasitology, 113, S217-S238.
7. Witty, M.J. (1999) Current strategies in the search for novel antiparasitic agents. Int. J. Parasitol., 29, 95-103.
8. Geary, T.G., Thompson, D.P., and Klein, R.D. (1999) Mechanism-based screening: discovery of the next generation of anthelmintics depends upon more basic research. Int. J. Parasitol., 29, 105-112.
9. Guido, R.V.C. and Oliva, G. (2009) Structure-based drug discovery for tropical diseases. Curr. Top.Med. Chem., 9, 824-843.
10. Postigo, M.P., Guido, R.V.C., Oliva, G., Castilho, M.S., Pitta, I.daR., de Albuquerque, J.F.C., and Andricopulo, A.D. (2010) Discovery of new inhibitors of Schistosoma mansoni PNP by pharmacophore-based virtual screening. J. Chem. Inf. Model., 50, 1693-1705.
11. Klein, R.D. and Geary, T.G. (1997) Recombinant microorganisms as tools for high-throughput screening for nonantibiotic compounds. J. Biomol. Screen., 2, 41-49.
12. Geary, T.G. (2001) Screening for parasiticides using recombinant microorganisms, in Enzyme Technology for Pharmaceutical and Biotechnological Applications (eds H.A. Kirst, W.-K. Yeh, M. Zmijewski, and D.B. Bronson), Dekker, New York, pp. 323-341.
13. Klein, R.D., Olson, E.R., Favreau, M.A., Winterrowd, C.A., Hatzenbuhler, N.T., Shea, M.H., Nulf, S.C., and Geary, T.G. (1991) Cloning of a cDNA encoding phosphofructokinase from Haemonchus contortus. Mol. Biochem. Parasitol., 48, 17-26.
14. Klein, R.D., Winterrowd, C.A., Hatzenbuhler, N.T., Shea, M.H., Favreau, M.A., Nulf, S.C., and Geary, T.G. (1992) Cloning of a cDNA encoding phosphoenolpyruvate carboxykinase from Haemonchus contortus. Mol. Biochem. Parasitol., 50, 285-294.
15. Klein, R.D., Favreau, M.A., Alexander-Bowman, S.J., Nulf, S.C., Vanover, L., Winterrowd, C.A., Yarlett, N., Martinez, M., Keithly, J.S., Zantello, M.A., Thomas, E.M., and Geary, T.G. (1997) Haemonchus contortus: cloning and functional expression of a cDNAencoding ornithine decarboxylase and development of a screen for inhibitors. Exp. Parasitol., 87, 171-184.
16. Eakin, A.E., Nives-Alicea, R., Tosado-Acevedo, R., Chin, M.S., Wang, C.C., and Craig, S.P. III (1995) Comparative complement selection in bacteria enables screening for lead compounds targeted to a purine salvage enzyme of parasites. Antimicrob. Agents Chemother., 39, 620-625.
17. Wu, B., Novelli, J., Foster, J., Vaisvila, R., Conway, L., Ingram, J., Ganatra, M., Rao, A.U.,Hamza, I., and Slatko, B. (2009) The heme biosynthetic pathway of the obligate Wolbachia symbiont of Brugia malayi as a potential anti-filarial drug target. PLoS Negl. Trop. Dis., 3, e45.
18. Simeonov, A., Jadhav, A., Sayed, A.A., Wang, Y., Nelson, M.E., Thomas, C.J., Inglese, J., Williams, D.L., and Austin, C.P. (2008) Quantitative highthroughput screen identifies inhibitors of the Schistosoma mansoni redox cascade. PLoS Negl. Trop. Dis., 2, e127.
19. Angelucci, F., Sayed, A.A., Williams, D.L., Boumis, G., Brunori, M., Dimastrogiovanni, D., Miele, A.E. et al. (2009) Inhibition of Schistosoma mansoni thioredoxin-glutathione reductase by auranofin. Structural and kinetic aspects. J. Biol. Chem., 284, 28977-28985.
20. Anderson, R., Van Rensburg, C.E., Joone, G.K., and Lessing, A. (1991) Auranofin inactivates phosphofructokinase in human neutrophils, leading to depletion of intracellular ATP and inhibition of superoxide generation and locomotion. Mol. Pharmacol., 40, 427-434.
21. Sayed, A.A., Simeonov, A., Thomas, C.J., Inglese, J., Austin, C.P., and Williams, D.L. (2008) Identification of oxadiazoles as new drug leads for the control of schistosomiasis. Nat. Med., 14, 407-412.
22. Kuhn, I., Kellenberger, E., Said-Hassane, F., Villa, P., Rognan, D., Lobstein, A., Haiech, J. et al. (2010) Identification by high-throughput screening of inhibitors of Schistosoma mansoni NAD{thorn} catabolizing enzyme. Biorg. Med. Chem., 18, 7900-7910.
23. Danel, F., Caspers, P., Nuoffer, C., Hartlein, M., Kron, M.A., and Page, M.G.P. (2011) Asparaginyl-tRNA synthetase pre-transfer editing assay. Curr. Drug Discov. Technol., 8, 66-75.
24. Yu, Z., Vodanovic-Jankovic, S., Ledeboer, N., Huang, S.-X., Rajski, S.R., Kron, M., and Shen, B. (2011) Tirandamycins from Streptomyces sp. 17944 inhibiting the parasite Brugia malayi asparagine tRNA synthetase. Org. Lett., 13, 2034-2037.
25. Gloeckner, C., Garner, A.L., Mersha, F., Oksov, Y., Trichoche, N., Eubanks, L.M., Lustigman, S., Kaufmann, G.F., and Janda, K.D. (2010) Repositioning of an existing drug for the neglected tropical disease Onchocerciasis. Proc. Natl. Acad. Sci. USA, 107, 3424-3429.
26. Garner, A.L., Gloeckner, C., Tricoche, N., Zakhari, J.S., Samje, M., Cho-Ngwa, F., Lustigman, S., and Janda, K.D. (2011) Design, synthesis and biological activities of closantel analogues: structural promiscuity and its impact on Onchocerca volvulus. J. Med. Chem., 54, 3963-3972.
27. Omura, S., Miyadera, H., Ui, H., Shiomi, K., Yamaguchi, Y., Masuma, R., Nagamitsu, T. et al. (2001) An anthelmintic compound, nafuredin, shows selective inhibition of complex I in helminth mitochondria. Proc. Natl. Acad. Sci. USA, 98, 60-62.
28. Ui, H., Shiomi, K., Suzuki, H., Hatano, H., Morimoto, H., Yamaguchi, Y., Masuma, R. et al. (2006) Verticipyrone, a new NADH-fumarate reductase inhibitor, produced by Verticillium sp. FKI-1083. J. Antibiot., 59, 785-790.
29. Taldone, T.,Gillan, V., Sun,W., Rodina, A., Patel, P., Maitland, K., O'Neill, K. et al. (2010) Assay strategies for the discovery and validation of therapeutics targeting Brugia malayi Hsp90. PLoS Negl. Trop. Dis., 4, e714.
30. Maule, A.G., Mousley, A., Marks, N.J., Day, T.A., Thompson, D.P., Geary, T.G., and Halton, D.W. (2002) Neuropeptide signaling systems - potential drug targets for parasite and pest control. Curr. Top. Med. Chem., 2, 733-758.
31. Greenwood, K., Williams, T., and Geary, T. (2005) Nematode neuropeptide receptors and their development as anthelmintic screens. Parasitology, 131, S169-S177.
32. Woods, D.J., Butler, C., Williams, T., and Greenwood, K. (2010) Receptor-based discovery strategies for insecticides and parasiticides: A review, in Neuropeptide Systems as Targets for Parasite and Pest Control (eds T.G. Geary and A.G. Maule), Landes Bioscience, Austin, TX, pp. 1-9.
33. Geary, T.G., Bowman, J.W., and Friedman, A.R. (1999) Method for discovering novel anthelmintic compounds. US Patent 5,859,188.
34. Lee, B.H., Dutton, F.E., Clothier, M.F., Thomas, E.W., Bowman, J.W., Davis, J.P., Johnson, S.S. et al. (1999) Synthesis and biological activity of anthelmintic thiadiazoles using an AF-2 receptor binding assay. Bioorg. Med. Chem. Lett, 9, 1727-1732.
35. Lowery, D.E., Geary, T.G., Kubiak, T.M., and Larsen, M.J. (2007) G protein-coupled receptor-like receptors and modulators thereof. US Patent 7,208,591.
36. McVeigh, P., Geary, T.G.,Marks, N.J., and Maule, A.G. (2006) The FLP-side of nematodes. Trends Parasitol., 22, 385-396.
37. Husson, S.J., Mertens, I., Janssen, T., Lindemans, M., and Schoofs, L. (2007) Neuropeptidergic signaling in the nematode Caenorhabditis elegans. Prog. Neurobiol., 82, 33-55.
38. Wang, Z.X., Broach, J.R., and Peiper, S.C. (2006) Functional expression of CXCR4 in Saccharomyces cerevisiae in the development of powerful tools for the pharmacological characterization of CXCR4. Methods Mol. Biol., 332, 115-127.
39. Minic, J., Sautel, M., Salesse, R., and Pajot-Augy, E. (2005) Yeast system as a screening tool for the pharmacological assessment of G protein coupled receptors. Curr. Med. Chem., 12, 961-969.
40. Geary, T.G.,Woods, D.J., Williams, T., and Nwaka, S. (2009) Target identification and mechanism-based screening for anthelmintics: application of veterinary antiparasitic research programmes to search for new antiparasitic drugs for human indications, in Drug Discovery in Infectious Diseases (ed. P.M. Selzer), Wiley-VCH Verlag GmbH,Weinheim, pp. 1-16.
41. Taman, A. and Ribeiro, P. (2009) Investigation of a dopamine receptor in Schistosoma mansoni: functional studies and immunolocalization. Mol. Biochem. Parasitol., 168, 24-33.
42. El-Shehabi, F. and Ribeiro, P. (2010) Histamine signaling in Schistosoma mansoni: immunolocalisation and characterisation of a new histamineresponsive receptor (SmGPR-2). Int. J. Parasitol., 40, 1395-1406.
43. Smith, M.W., Borts, T.L., Emkey, R., Cook, C.A., Wiggins, C.J., and Gutierrez, J.A. (2003) Characterization of a novel G-protein coupled receptor from the parasitic nematode H. contortus with a high affinity for serotonin. J. Neurochem., 86, 255-266.
44. White,W.H., Gutierrez, J.A., Naylor, S.A., Cook, C.A., Gonzalez, I.C., Wisehart, M.A., Smith, C.K. II, and Thompson, W.A. (2007) In vitro and in vivo characterization of p-aminophenethyl-m-trifluoromethylphenyl piperazine (PAPP), a novel serotonergic agonist with anthelmintic activity against Haemonchus contortus, Teladorsagia circumcincta and Trichostrongylus colubriformis. Vet. Parasitol., 146, 58-65.
45. Aguinaldo, A.M., Turbeville, J.M., Linford, L.S., Rivera, M.C., Garey, J.R., Raff, R.A., and Lake, J.A. (1997) Evidence for a clade of nematodes, arthropods and moulting animals. Nature, 387, 489-493.
46. Geary, T.G. and Moreno, Y. (2011) Macrocyclic lactone anthelmintics: spectrum of activity and mechanism of action. Curr. Pharm. Biotechnol., Epub ahead of print.
47. Shiomi, K., Matsui, R., Kakei, A., Yamaguchi, Y., Masuma, R., Hatano, H., Arai, N., Isozaki, M., Tanaka, H., Kobayashi, S., Turberg, A., and _Omura, S. (2010) Verticilide, a new ryanodinebinding inhibitor, produced byVerticillium sp. FKI-1033. J. Antibiot., 63, 77-82.
48. Ho, N.F.H., Sims, S.M., Vidmar, T.J., Day, J.S., Barsuhn, C.L., Thomas, E.M., Geary, T.G., and Thompson, D.P. (1994) Theoretical perspectives on anthelmintic drug discovery: interplay of transport kinetics, physicochemical properties and in vitro activities of anthelmintic drugs. J. Pharm. Sci., 83, 1052-1059.